Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4471131
Max Phase: Preclinical
Molecular Formula: C37H54N6O5S
Molecular Weight: 694.94
Molecule Type: Unknown
Associated Items:
ID: ALA4471131
Max Phase: Preclinical
Molecular Formula: C37H54N6O5S
Molecular Weight: 694.94
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CN3CCC(N(C)C)CC3)c3cc[nH]c3n2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C37H54N6O5S/c1-8-35(4)19-27(36(5)22(2)9-14-37(23(3)31(35)47)15-10-26(44)30(36)37)48-29(46)21-49-34-40-32-25(11-16-38-32)33(41-34)39-28(45)20-43-17-12-24(13-18-43)42(6)7/h8,11,16,22-24,27,30-31,47H,1,9-10,12-15,17-21H2,2-7H3,(H2,38,39,40,41,45)/t22-,23+,27-,30+,31+,35-,36+,37+/m1/s1
Standard InChI Key: VKNDFGUUXCPJJQ-AIEHSFANSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 694.94 | Molecular Weight (Monoisotopic): 694.3876 | AlogP: 4.92 | #Rotatable Bonds: 9 |
Polar Surface Area: 140.75 | Molecular Species: BASE | HBA: 10 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.47 | CX Basic pKa: 9.67 | CX LogP: 4.03 | CX LogD: 2.03 |
Aromatic Rings: 2 | Heavy Atoms: 49 | QED Weighted: 0.14 | Np Likeness Score: 0.25 |
1. Deng Y, Wang XZ, Huang SH, Li CH.. (2019) Antibacterial activity evaluation of synthetic novel pleuromutilin derivatives in vitro and in experimental infection mice., 162 [PMID:30445267] [10.1016/j.ejmech.2018.11.006] |
Source(1):